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Abstract
Despite overwhelming evidence implicating the prion protein (PrP) in prion disease pathogenesis, the normal function of
this cell surface glycoprotein remains unclear. In previous reports we demonstrated that PrP mediates cellular iron uptake
and transport, and aggregation of PrP to the disease causing PrP-scrapie (PrP
Sc) form results in imbalance of iron
homeostasis in prion disease affected human and animal brains. Here, we show that selective deletion of PrP in transgenic
mice (PrP
KO) alters systemic iron homeostasis as reflected in hematological parameters and levels of total iron and iron
regulatory proteins in the plasma, liver, spleen, and brain of PrP
KO mice relative to matched wild type controls. Introduction
of radiolabeled iron (
59FeCl3) to Wt and PrP
KO mice by gastric gavage reveals inefficient transport of
59Fe from the
duodenum to the blood stream, an early abortive spike of erythropoiesis in the long bones and spleen, and eventual
decreased
59Fe content in red blood cells and all major organs of PrP
KO mice relative to Wt controls. The iron deficient
phenotype of PrP
KO mice is reversed by expressing Wt PrP in the PrP
KO background, demonstrating a functional role for PrP
in iron uptake and transport. Since iron is required for essential metabolic processes and is also potentially toxic if
mismanaged, these results suggest that loss of normal function of PrP due to aggregation to the PrP
Sc form induces
imbalance of brain iron homeostasis, resulting in disease associated neurotoxicity.
Citation: Singh A, Kong Q, Luo X, Petersen RB, Meyerson H, et al. (2009) Prion Protein (PrP) Knock-Out Mice Show Altered Iron Metabolism: A Functional Role for
PrP in Iron Uptake and Transport. PLoS ONE 4(7): e6115. doi:10.1371/journal.pone.0006115
Editor: Joseph El Khoury, Massachusetts General Hospital and Harvard Medical School, United States of America
Received February 4, 2009; Accepted May 20, 2009; Published July 1, 2009
Copyright:  2009 Singh et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: NIH grants NS39089 and NS35962 to NS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the
manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: neena.singh@case.edu
Introduction
Prion protein (PrP) is a ubiquitously expressed cell surface
glycoprotein linked to the plasma membrane by a glycosylpho-
sphatidylinositol (GPI) anchor. Although several lines of evidence
support the obligate role of PrP in animal and human prion
disorders, relatively less is known about the normal function of this
protein [1,2]. Attempts to understand the physiological function of
PrP by generating PrP knock-out (PrP
KO) transgenic mouse lines
have been futile since the mice do not develop an overt phenotype
other than resistance to prion disease [3]. The limited information
on possible physiological function(s) of PrP has been obtained from
the Zurich 1 and Edinburgh PrP
KO mice since these do not up-
regulate Doppel, a PrP homologue that induces cerebellar
degeneration [4,5]. Most of the investigations on these and other
mouse models have focused on brain function since PrP is most
abundant on neuronal cells and is therefore likely to alter brain
function by its absence. A similar loss of function due to
aggregation of PrP to the disease causing PrP-scrapie (PrP
Sc) form
is also likely to alter neuronal function, partially explaining the
pathogenesis of prion disorders and justifying the focus [2]. Several
important facts have emerged from these studies; PrP
KO mice
show altered circadian rhythm and sleep pattern, increased
susceptibility to neuronal damage by oxidative stress and cerebral
ischemia, neurotoxicity by expression of Doppel and N-terminally
truncated PrP, increased predilection to seizures, motor and
cognitive abnormalities, reduced synaptic inhibition and long term
potentiation in the hippocampus, altered development of the
granule cell layer, mis-regulation of the cerebellar network, and
age-dependent spongiform change with reactive astrogliosis [5–
10]. Examination of peripheral organ systems reveals impaired
ability of hematopoietic progenitor cells of PrP
KO mice to colonize
when transplanted to irradiated recipient mice [11], and poor
recovery of PrP lacking animals from experimentally induced
anemia [12]. The multiplicity of observations attributed to the
absence of PrP in the same transgenic mouse line suggests its
involvement in an essential function with broad implications.
Though attractive, this hypothesis has remained untested.
Recently, we demonstrated that PrP mediates iron uptake and
transport in human neuroblastoma cells [13], and aggregation of
PrP to the disease causing PrP-scrapie (PrP
Sc) form induces an
imbalance of iron homeostasis in prion disease affected human,
hamster and mouse brains [14]. Here, we extend the cell based
studies to mouse models to understand the role of PrP in iron
metabolism in vivo. Using the Zurich 1 PrP
KO and matched wild
type (Wt) mice expressing normal levels of PrP as experimental
models, we demonstrate that PrP
KO mice show a phenotype of
systemic iron deficiency and altered iron homeostasis compared to
Wt controls. The underlying cause of this abnormality is impaired
transport of iron from the duodenal epithelium to the blood
stream, and a similar defect in iron uptake by parenchymal cells of
various organs and hematopoietic precursor cells. The iron
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KO mice is rescued by re-introducing
PrP on the PrP
KO background, indicating a functional role for PrP
in iron uptake and transport. Since iron is an essential element that
is necessary for survival but can be extremely toxic if mis-managed
[15], these results have significant implications for understanding
the physiological function of PrP in cellular iron metabolism, and
the pathological implications thereof due to its aggregation to the
PrP
Sc form, the principal agent responsible for prion disease
associated neuronal death.
Results
Major organs of PrP
KO mice show a phenotype of relative
iron deficiency
Since PrP is expressed most abundantly on neurons, the effect of
PrP deletion on brain iron homeostasis was assessed in PrP
KO and
matched Wt controls. In iron deficiency, we expect low levels of
total iron, decreased levels of iron storage protein ferritin, and
increased levels of iron uptake proteins Tf and TfR in the affected
tissue. To evaluate these parameters, equal quantity of protein
from brain homogenates of PrP
KO and Wt mice was fractionated
by SDS-PAGE and immunoblotted (Figure 1A). Probing for PrP
reveals the expected glycoforms migrating between 27–37 kDa in
Wt, and complete absence of PrP in PrP
KO samples as expected.
Probing for ferritin shows a decrease in H- and L-chain isoforms in
PrP
KO samples relative to Wt controls. Tf and TfR, on the other
hand, show a relative increase in PrP
KO samples. Probing for b-
actin confirms that the observed differences are not an artifact of
protein loading (Figure 1A, lanes 1–6). Quantification by
densitometry shows a decrease in ferritin levels by 59% and an
increase in Tf and TfR levels by 58% and 245% respectively in
PrP
KO samples relative to Wt controls (Figure 1B).
Brain homogenate represents a mixture of different cell types and
the aboveresults do not necessarily reflect the iron status of neurons,
the cell population most vulnerable to alterations in iron
homeostasis. To evaluate the iron status of neurons, unfixed brain
sections from Wt and PrP
KO mice were incubated with FITC-
tagged Tf for 15 minutes at 37uC [16], washed gently with cold PBS
to remove unbound Tf, and fixed with paraformaldehyde. A set of
control samples were pre-incubated with unlabeled apo-Tf for 15
minutes before exposure to FITC-Tf to compete for binding sites.
Examination by fluorescence microscopy shows significantly more
binding of FITC-Tf to the cerebellar Purkinje cell layer of PrP
KO
brain sections compared to Wt controls, suggesting higher
expression of TfR in PrP
KO neurons (Figure 2A, panels 1 and 2,
white arrow). The binding of FITC-Tf is inhibited competitively by
pre-incubation of brain sections with unlabeled apo-Tf, indicating
the specificity of the reaction (Figure 2A, panels 3 and 4, white
arrow-head). To further analyze the state of iron deficiency in
PrP
KO brains, equal counts of
59FeCl3 were injected in the tail vein
of Wt and PrP
KO mice, and after a chase of 3 hours, mice were
euthanized and cold PBS was infused from the heart to drain
capillary blood. Subsequently, brains were harvested, counted in a
c-counter, and fixed overnight in formalin. Subsequently, 700 mM
sections were cut and exposed to X-ray film. Brains of PrP
KO mice
take up 45% more
59Fe relative to Wt controls as estimated by total
counts and visualization on X-ray film exposed to dry sections
(Figure 2B, panels 1–4, black arrows). These results indicate a state
of relative iron deficiency and consequent increased transport of
59Fe to the brains of PrP
KO mice.
Figure 1. Brain homogenates of PrP
KO mice show evidence of iron deficiency. (A) Immunoblot analysis of Wt and PrP
KO brain homogenates
with PrP specific antibody 8H4 shows the expected glycoforms of PrP in Wt samples migrating between 27–37 kDa, and no reaction with PrP
KO
samples as expected (lanes 1–6). Immunoreaction for ferritin, Tf, and TfR shows significantly less ferritin, and more Tf and TfR levels in PrP
KO samples
compared to Wt controls (lanes 1–6). Reaction for b-actin confirms similar loading of protein. (B) Quantitative estimation of proteins in (A) after
normalization with b-actin shows a decrease in ferritin, and an increase in Tf and TfR levels in PrP
KO samples compared to Wt controls. Values are
mean6SEM. *p,0.001, **p,0.01 relative to Wt. n=6.
doi:10.1371/journal.pone.0006115.g001
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KO mice show up regulation of TfR and increased transport of iron from the blood stream. (A)
Incubation of unfixed brain sections with FITC-Tf shows significantly more binding to the Purkinje cell neurons of PrP
KO sample compared to Wt
controls (panels 1 and 2) [16]. Pre-incubation of brain sections with unlabeled apo-Tf decreases the signal significantly in both samples (panels 3 and
4), demonstrating the specificity of binding. The assay was performed on three sections each from three different sets of mice. A representative
section is shown. (B) Autoradiograph of brain sections prepared from Wt and PrP
KO mice injected with
59FeCl3 intravenously shows significantly more
59Fe in PrP
KO sections compared to Wt controls (panels 1–4). A scan of brain sections exposed to the film in panels 2 and 4 respectively is shown
(panels 5 and 6). (Two consecutive 700 mM sections from each brain sample are shown.
59Fe is visible as radio-opaque black dots.
doi:10.1371/journal.pone.0006115.g002
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observed in other major organs of PrP
KO mice, the iron content
and levels of the iron management proteins ferritin and Tf were
evaluated in the liver of Wt and PrP
KO mice. Frozen sections of
Wt and PrP
KO liver were stained for iron with Prussian blue and
examined. PrP
KO sections show significantly less iron in Kupffer
cells and hepatocytes relative to Wt controls (Figure 3A, panels 1
and 2). Fractionation of liver homogenates on a non-denaturing
gel followed by in-gel reaction with Ferene-S shows lower iron
content in PrP
KO liver ferritin compared to Wt controls (Figure 3B,
lanes 1–4) [17]. (The identity of the blue band as ferritin was
established by immunoblotting as described previously [13]).
Evaluation of ferritin and Tf expression in liver homogenates
shows significantly lower levels of ferritin and higher levels of Tf in
PrP
KO samples compared to Wt controls (Figure 3C, lanes 1–6).
Quantification by densitometry shows a decrease in the iron
content and expression of ferritin by 48% and 66% respectively,
and an increase in the expression level of Tf by 44% in PrP
KO
samples relative to Wt controls (Figure 3D).
A similar analysis of spleen sections shows intense reaction for
iron with the Perl’s stain in both Wt and PrP
KO samples
(Figure 4A, panels 1 and 2). In-gel reaction of spleen ferritin with
Ferene-S shows a decrease in the iron content and expression of
ferritin in PrP
KO samples relative to Wt controls (Figures 4B and
C, lanes 1–6). Quantification by densitometry shows a decrease in
the iron content and expression of ferritin by 27%, and 64% in
PrP
KO samples compared to Wt controls (Figure 4D). Re-probing
of the membrane for Tf and TfR did not show a significant
difference in the expression of these proteins (data not shown).
Together, the above results suggest a phenotype of relative iron
deficiency in the brain, liver, and spleen of PrP
KO mice compared
to Wt controls. Subsequent studies were directed at characterizing
the iron deficient phenotype of PrP
KO mice and the mechanistic
basis of this finding.
The iron deficiency of PrP
KO mice is largely compensated
To evaluate if the phenotype of iron deficiency in PrP
KO mice is
due to low circulating iron, hematological parameters were
evaluated by an automated blood chemistry analyzer optimized
for mouse samples. Hemoglobin, serum iron, Tf saturation, and
serum ferritin are decreased in PrP
KO samples by 3.5, 21.6, 37.6
and 50.1% respectively, while the reticulocyte count and total iron
binding capacity (TIBC) are increased by 42.2 and 24.0%
respectively in PrP
KO samples relative to matched Wt controls
(Table 1). The total red cell count and hematocrit show minimal
differences between the two groups. Bone marrow smears revealed
an increase in red cell precursors in PrP
KO samples, indicating an
attempt by the iron homeostatic machinery to compensate for the
iron deficiency in PrP
KO animals (data not shown).
Subsequent studies were directed at determining whether the
iron deficiency in PrP
KO mice arises from inefficient uptake and/
or transport of iron from ingested food, defective uptake by target
Figure 3. Liver of PrP
KO mice displays a phenotype of iron deficiency. (A) Prussian blue staining of frozen sections shows minimal reaction
for iron in the PrP
KO sample compared to Wt controls. (B) In-gel reaction of homogenates with Ferene-S shows significantly less iron content of PrP
KO
ferritin compared to Wt controls (lanes 1–4). (C) Immunoreaction of homogenates with anti-ferritin antibody specific for H and L chains shows
significantly less ferritin expression in PrP
KO samples compared to Wt controls (lanes 1–6). Re-probing for Tf shows an increase in Tf expression in
PrP
KO samples relative to Wt controls (lanes 1–6). Levels of b-actin are similar in all samples, confirming that the observed differences are not an
artifact of protein loading (lanes 1–6). (D) Quantification by densitometry shows a significant reduction in the iron content and expression of ferritin,
and an increase in Tf expression in PrP
KO samples compared to matched Wt controls. Values are mean6SEM, n=3. *p,0.001 relative to Wt.
doi:10.1371/journal.pone.0006115.g003
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processes.
PrP mediates iron uptake and/or transport from the
duodenum to the blood stream
The uptake and transport of ingested iron from the intestinal
lumen to the blood stream and target organs of Wt and PrP
KO
mice was evaluated by introducing radioactive iron into the
stomach, and quantifying
59Fe uptake by various organs after
defined time points of chase. The following organs were evaluated:
1) stomach with attached duodenum, jejunum, and a small piece
of ileum, 2) liver, 3) spleen, 4) brain, 5) femurs, and 6) tibial bones.
Washed upper gastrointestinal tract was vacuum-dried and
exposed to X-ray film (Figure 5A), and after obtaining adequate
film exposures,
59Fe incorporated in the upper 10 cm of the
duodenum was quantified in a c-counter. Whole blood, washed
red blood cells (RBCs), plasma, organs, and bones were counted in
a c-counter to quantify
59Fe incorporation.
Autoradiographs of duodenum samples demonstrate significantly
more
59Fe in PrP
KO samples at each time point compared to Wt
Figure 4. Spleen of PrP
KO mice displays a phenotype of iron deficiency. (A) Prussian blue staining of frozen sections shows a prominent
reaction in the reticulo-endothelial cells of PrP
KO and Wt samples. (B) In-gel reaction of homogenates with Ferene-S shows less iron content of PrP
KO
ferritin compared to Wt controls (lanes 1–6). (C) Immunoreaction of homogenates with L-chain specific anti-ferritin antibody shows significantly less
expression in PrP
KO samples compared to Wt controls (lanes 1–6). Re-probing for b-actin confirms that the difference is not an artifact of protein
loading (lanes 1–6). (D) Quantification by densitometry after normalization with b-actin shows a significant reduction in the iron content and
expression of ferritin in PrP
KO samples compared to matched Wt controls. Values are mean6SEM, n=3. *p,0.01 relative to Wt.
doi:10.1371/journal.pone.0006115.g004
Table 1. Hematological parameters in Wt and PrP
KO mice.
Wt PrP
KO
% change
in PrP
KO N
RBC (10
12/L) 9.2360.12 9.2060.33 NS 14
Hematocrit (%) 49.0161.08 49.0561.45 NS 14
Hemoglobin (g/dl) 14.5460.19 14.0260.28*** Q 3.5 14
Reticulocytes (%) 3.4660.23 4.9260.27* 42.2q 10
Serum iron (mg/dl) 325.066.91 254.5614.8* Q 21.6 6
TIBC (mg/dl) 451.73625.8 561.09636.61** 24.0 q 6
Tf saturation (%) 70.3164.52 43.8666.12** Q 37.6 6
Serum ferritin (ng/dl) 98.5164.82 49.1366.43* Q 50.1 6
Values are mean6SEM.
*p,0.001,
**p,0.01,
***p,0.05 as compared to Wt. NS:
not significant; N: number of animals in each group; RBCs: red blood cells; TIBC:
total iron binding capacity; Tf: transferrin; Q: decrease; q: increase.
doi:10.1371/journal.pone.0006115.t001
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59Fe in
the duodenum of PrP
KO mice is significantly higher than Wt
samples even after 11 days of chase (Figure 5A, lanes 11 and 12).
Samplesinlanes1–8wereexposed toX-rayfilmfor2 hours,lanes9
and 10 for 24 hours, and lanes 11 and 12 for 6 days to highlight the
difference in
59Fe content between Wt and PrP
KO samples
(Figure 5A, lanes 9–12). Quantitative analysis of these results was
performed by counting the first 10 cm of the duodenum from each
sample in a c-counter. As expected, both samples show a gradual
decline in
59Fe counts with increasing chase time, falling to 0.1% of
the initial value after 11 days of chase. However, PrP
KO samples
show higher retention of
59Fe by 21, 60, 87, 32, and 57% relative to
matched Wt controls after a chase of 1, 4, 24, and 48 hours and 11
days respectively (Figure 5B). Mice ranging in age from 3–6 months
and blinded to the person performing the experiment yielded
similar results. The 1 and 4 hour chase time points were repeated
more than 6 times.
To evaluate whether increased retention of
59Fe in the
duodenum of PrP
KO mice is due to sequestration in ferritin
within enterocytes,
59FeCl3 fed Wt and PrP
KO mice were chased
for 4 hours, and the first 5 cm of the duodenum was homogenized
and fractionated on a non-denaturing gel to identify
59Fe-labeled
proteins as described previously [13]. A single iron labeled band
that immunoreacts for ferritin is detected in Wt and PrP
KO
samples (Figure 6A, lanes 1–4). The iron content and expression of
ferritin are higher in the PrP
KO sample compared to Wt control,
explaining the significantly higher
59Fe content in the duodenum
of PrP
KO mice (Figure 6A, lanes 1–4). Fractionation of the same
samples by SDS-PAGE followed by immunoblotting confirms that
ferritin levels are significantly higher in the PrP
KO sample
(Figure 6A, lanes 5 and 6). (The identity of iron labeled bands in
lanes 1 and 2 was confirmed by eluting labeled proteins from these
bands and re-fractionating on SDS-PAGE followed by immuno-
blotting as described previously [13]). Quantification by c-
counting and densitometry shows an increase in the
59Fe content
of ferritin by 42% and expression of ferritin by 119% in PrP
KO
samples relative to matched Wt controls (Figure 6B).
These results indicate that PrP
KO mice take up more
59Fe from
the intestinal lumen and/or release less into the blood stream
compared to Wt controls, resulting in the accumulation of
59Fe in
the duodenal epithelium.
PrP facilitates iron uptake by parenchymal cells and
hematopoietic precursor cells
Transport of iron from the duodenal epithelium to the blood
stream and subsequent uptake by various organs was evaluated by
quantifying
59Fe in the plasma, washed RBCs, and various organs
in a c-counter, and fractionating the plasma using a non-
denaturing gel to evaluate the
59Fe content of Tf. The
59Fe
counts in the plasma of PrP
KO mice are decreased by 12% after
Figure 5. Iron is retained in the duodenum of PrP
KO mice. (A) Autoradiogram of upper gastrointestinal tract of Wt and PrP
KO mice fed 20 mCi
of
59FeCl3 by gastric gavage shows higher levels of
59Fe in PrP
KO samples after 1, 4, 24, and 48 hours of chase (lanes 1–10). The difference becomes
more obvious after 11 days of chase (lanes 11 and 12). (Lanes 9 and 10 were exposed for 24 hours and lanes 11 and 12 for 6 days to observe the
difference clearly). A representative experiment out of a total of three is shown. (B) Quantification of
59Fe in the first 10 cm of the duodenum shows
significantly higher
59Fe in the PrP
KO samples at all time points tested compared to matched Wt controls. Values are mean6SEM, n=3. *p,0.01 as
compared to Wt.
doi:10.1371/journal.pone.0006115.g005
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48 hours and 11 days of chase respectively relative to Wt controls
(Figure 7, plasma). Red blood cells show no incorporation of
59Fe
after 1 hour as expected, a sudden increase in PrP
KO samples by
537% after 4 hours, and a decrease by 60, 48, and 63% after 24
and 48 hours and 11 days respectively relative to Wt controls
(Figure 7, red cells). The spleen of PrP
KO mice shows 62% less
59Fe after 1 hour, an increase by 831% after 4 hours, followed by
a precipitous fall by 64% of Wt values after 24 hours that is
maintained throughout 11 days of chase (Figure 7, spleen).
Likewise, the femurs of PrP
KO mice show 25% less
59Fe after
1 hour, an increase by 261 and 17% after 4 and 24 hours, and a
decline by 39% after 11 days respectively relative to Wt controls.
Femurs of Wt mice also show a spike in
59Fe after 24 hours of
chase, but the increase is significantly less than PrP
KO samples
(Figure 7, Femur). The liver of PrP
KO mice shows an increase in
59Fe by 47 and 82% after 1 and 4 hours, an increase by 339%
after 24 hours, and a precipitous fall by 69% after 11 days of chase
relative to Wt controls (Figure 7, liver). Brain samples show
variability during the first 48 hours of chase in both PrP
KO and Wt
mice, but after 11 days there is a significant decrease in PrP
KO
samples by 69% of Wt values (Figure 7, brain).
Fractionation of plasma by non-denaturing gel electrophoresis
followed by autoradiography reveals the presence of
59Fe-Tf in Wt
and PrP
KO samples as expected (Figure 8A) (The identity of
59Fe
labeled band as Tf was established by immunoblotting as reported
earlier [13]). The
59Fe content of Tf in the PrP
KO sample is lower
after 1 hour and significantly higher after 4 and 24 hours of chase
relative to Wt controls (Figure 8A, lanes 1–6). Minimal signal is
detected after 48 hours of chase in either of the samples (Figure 8A,
lanes 7 and 8). Evaluation of the
59Fe content of RBCs spotted on
a PVDF membrane followed by autoradiography shows increased
incorporation in PrP
KO samples after 4 hours and minimal
increase thereafter until 48 hours of chase. Wt samples, on the
other hand, show significant incorporation after 24 hours and
almost doubling of the counts by 48 hours (Figure 8B), reflecting
the values in Figure 7 above. These results indicate inefficient
transport of
59Fe from the duodenum of PrP
KO mice to the blood
stream, but much faster kinetics of incorporation into RBC
precursors by 4 hours of chase and minimal increase thereafter. In
contrast, Wt mice show significantly higher transport of
59Fe to the
blood stream, incorporation into RBCs at the expected chase time
of 24 hours, and a linear increase in the
59Fe content of RBCs
thereafter. Since the majority of Tf-bound
59Fe is taken up by
newly synthesized RBCs, the increase in plasma
59Fe-Tf in PrP
KO
mice after 4 hours of chase relative to Wt controls indicates
decreased uptake as evidenced by the lower
59Fe content of PrP
KO
RBCs (Figure 8A, lanes 3–6).
Together, the above results indicate that the transport of iron
from the duodenal enterocytes to the blood stream and uptake by
Figure 6. Iron is retained within ferritin in the duodenal epithelium of PrP
KO mice. (A) The 4 hour duodenum samples in Figure 5 above
were homogenized and separated on a non-denaturing gel followed by autoradiography (lanes 1 and 2). The level of
59Fe labeled ferritin is
significantly higher in the PrP
KO sample compared to matched Wt control (lanes 1 and 2). Transblotting under native conditions followed by
immunoblotting for ferritin confirms the identity of
59Fe labeled bands as ferritin (lanes 3 and 4). Fractionation of the same samples by SDS-PAGE
followed by immunoblotting shows relatively more ferritin in the PrP
KO sample compared to matched Wt control (lanes 5 and 6). (B) Quantification
by densitometry shows significantly more
59Fe-ferritin and ferritin protein levels in the duodenum of PrP
KO mice relative to matched Wt controls.
Values are mean6SEM, n=3. *p,0.001 relative to Wt.
doi:10.1371/journal.pone.0006115.g006
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KO mice and
follows different kinetics of utilization relative to Wt controls. It is
likely that PrP
KO mice make an early attempt at erythropoiesis
because of their iron deficient state, but are unable to incorporate
enough iron into RBCs due to defective uptake by hematopoietic
progenitor cells. The lower
59Fe content of PrP
KO RBCs is not due
to a shorter life-span of these cells since their
59Fe counts remain
constant throughout 11 days of chase (Figure 7), the normal half-
life of murine RBCs. No signs of hemolysis were detected at any
time point of chase by urine-analysis (data not shown).
Iron deficient phenotype of PrP
KO mice is not due to
sequestration of iron in reticulo-endothelial cells
To rule out low level of hemolysis combined with sequestration
of
59Fe in cells of the reticulo-endothelial system in PrP
KO mice,
spleens harvested after 1–48 hours of chase (as in Figure 7 above)
were homogenized, and equal quantity of protein was fractionated
by non-denaturing gel electrophoresis followed by autoradiogra-
phy. Prominent bands of
59Fe-ferritin and
59Fe-Tf are detected in
the PrP
KO sample after 4 hours of chase revealing
59Fe content
several-fold higher than matched Wt controls (Figure 9, lanes 3
Figure 7. Distribution of
59Fe in Wt and PrP
KO mice. Plasma:
59Fe in PrP
KO samples is lower after 1 hour, increases by 48 hours, and falls to
values below Wt after 11 days of chase. RBCs: Wt RBCs show
59Fe incorporation after 24 hours, and the amount increases steadily till 11 days of
chase. PrP
KO RBCs, on the other hand, incorporate
59Fe relatively sooner after 4 hours, and show only a modest increase till 11 days of chase. Except
for the 4 hour chase time, the amount of
59Fe in PrP
KO RBCs is significantly lower than Wt controls, especially after 11 days of chase. Spleen: Wt
samples show a slight increase in
59Fe after 24 hours, and minimal change thereafter. PrP
KO spleens, on the other hand, show a significant increase
after 4 hours, followed by a precipitous fall after 24 hours. Femur: Kinetics of
59Fe uptake mirrors that of the spleen. PrP
KO samples show a spike at
4 hours that is maintained till 24 hours, followed by a fall. Wt samples show a delayed peak at 24 hours, and a fall to similar levels as the PrP
KO sample
after 11 days. Liver: Wt samples show a steady increase in
59Fe till 11 days of chase. PrP
KO samples, on the other hand, show a peak at 24 hours, and
the counts fall thereafter to values significantly lower than Wt controls. Brain: Wt and PrP
KO samples do not show much difference at early time
points of chase, but
59Fe incorporation in the PrP
KO sample is significantly lower than Wt controls after 11 days of chase. Values are mean6SEM of
three independent experiments. *p,0.01, **p,0.001 relative to Wt.
doi:10.1371/journal.pone.0006115.g007
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unlikely that reticulo-endothelial cells sequester the incorporated
59Fe (Figure 9, lanes 5–8). At all other time points the Wt sample
shows slightly higher
59Fe-ferritin and
59Fe-Tf compared to PrP
KO
samples (Figure 9, lanes 1, 2, and 5–8). The identity of
59Fe labeled
bands as ferritin and Tf was established by immunoblotting under
native conditions as described previously [13].
Further confirmation of the above results was obtained by
culturing peritoneal macrophages from Wt and PrP
KO mice
overnight, loading them with
59FeCl3-citrate complex after
stimulation with LPS [18], and monitoring release of
59Fe into
the medium in a c-counter. Macrophages from PrP
KO mice
release 17% of intracellular iron into the medium compared to
13% from the Wt sample during a chase of 18 hours, making it
unlikely that sequestration of
59Fe in the reticulo-endothelial cells
is responsible for the iron deficient phenotype of PrP
KO mice
(Table 2).
Expression of wild type PrP rescues the iron deficient
phenotype of PrP
KO mice
Since the only difference between Wt and PrP
KO mice is the
absence of PrP expression in the latter, a single allele of Wt PrP
was re-introduced on the PrP
KO background to generate PrP
+
mice. To assess the expression levels of PrP in PrP
+ mice relative to
Wt controls, an equal quantity of protein from brain homogenates
Figure 8. Time course of
59Fe distribution in the blood of Wt and PrP
KO mice. (A): Equal volume Wt and PrP
KO plasma collected at different
time points of chase were separated on a non-denaturing gel followed by autoradiography. After 1 hour of chase,
59Fe-Tf in the PrP
KO sample is lower
than matched Wt controls (lanes 1 and 2). However, the ratio reverses thereafter, and the level of
59Fe-Tf in the PrP
KO sample is higher than Wt
controls after 4, 24, and 48 hours of chase (lanes 3–8). (B) RBCs of Wt mice show minimal levels of
59Fe after 1 and 4 hours, and significant increase
after 24 and 48 hours of chase. PrP
KO mice, on the other hand, show iron counts at 4 hours, and minimal increase thereafter.
doi:10.1371/journal.pone.0006115.g008
Figure 9. Kinetics of
59Fe uptake by Wt and PrP
KO spleen. Autoradiogram of Wt and PrP
KO spleen homogenates separated on a native gel
show significantly higher
59Fe-ferritin and
59Fe-Tf in the PrP
KO sample after 4 hours of chase (lanes 3 and 4). At other time points Wt samples show
higher levels of
59Fe in ferritin and Tf bands relative to PrP
KO samples (lanes 1 and 2 and 5–8). (The identity of ferritin and Tf bands was confirmed by
immunoblotting [13]).
doi:10.1371/journal.pone.0006115.g009
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KO, and PrP
+ mice was fractionated by SDS-PAGE and
immunoblotted. Probing for PrP shows the expected glycoforms of
PrP migrating between 27–37 kDa in Wt and PrP
+ samples
(Figure 10A, lanes 1 and 3). Quantification by densitometry shows
slightly higher PrP expression in PrP
+ mice, ,10% relative to Wt
controls. PrP
KO samples do not react for PrP as expected
(Figure 10A, lane 2). Thus, PrP
+ mice are a suitable model to
test whether expression of PrP rescues the iron deficient phenotype
of PrP
KO mice.
To reduce variability, littermate PrP
KO and PrP
+ mice were
obtained by crossing PrP
+ and PrP
KO breeding pairs. After
confirming the genotype (data not shown), littermate PrP
+ and
PrP
KO, Wt, and PrP
KO mice were evaluated for iron uptake and
transport by introducing equal amounts of
59FeCl3 by gastric
gavage as in Figures 5 and 7 above (Figure 10B and C). Only the
4 hour chase time point was assessed since the maximum
differences between Wt and PrP
KO mice are observed at this
time point (Figure 5 and 7 above). Autoradiography of duodenum
samples shows significantly more
59Fe in the PrP
KO sample
compared to the Wt control as noted in Figure 5 above
(Figure 10B, lanes 1 and 2). Notably, a similar difference is seen
between PrP
KO and PrP
+ littermates (Figure 10B, lanes 3 and 4),
Table 2. Release of
59Fe from peritoneal macrophages after
18 hours.
Intracellular Secreted (18 h) % Secreted
Wt 151689612376 203116328 13%
PrP
KO 14141361995 240546604* 17%
Values are mean6SEM of cells plated in triplicate from two different sets of
mice.
*p,0.01 compared to Wt.
doi:10.1371/journal.pone.0006115.t002
Figure 10. Iron deficiency in PrP
KO mice is reversed by expressing Wt PrP. (A) Immunoblot analysis of Wt and littermate PrP
KO and PrP
(+)
brain homogenates for PrP shows the expected glycoforms of PrP in Wt and PrP
(+) samples (lanes 1 and 3), and no reaction in the PrP
KO sample as
expected (lane 2). (B) Autoradiogram of the upper gastrointestinal tract of Wt and littermate PrP
(+) and PrP
KO mice fed
59FeCl3 by gastric gavage as
above and chased for 4 hours shows significantly more
59Fe in the PrP
KO sample relative to Wt control (lanes 2 and 4). Notably, the
59Fe content of
PrP
(+) duodenum is similar to Wt, and significantly less than the littermate PrP
KO sample (lanes 1, 3 and 4). (C) Quantification of
59Fe in the first 10 cm
of the duodenum shows significantly more
59Fe in the PrP
KO sample compared to matched Wt control. Similarly, more
59Fe is detected in the PrP
KO
sample compared littermate PrP
(+) control. One way ANOVA shows a significant difference in
59Fe incorporation between Wt and PrP
KO, Wt and
littermate PrP
KO, PrP
(+) and littermate PrP
KO, and PrP
KO and PrP
(+) (p,0.0001). Post hoc Bonferroni tests show significant difference in
59Fe in PrP
KO as
well as littermate PrP
(+) and PrP
KO duodenums compared to Wt control (*p,0.01; #p,0.05). PrP
(+) exhibit significant difference compared to PrP
KO
($p,0.01), and littermate PrP
(+) and PrP
KO also differ significantly (@p,0.01). Values are mean6SEM, n=3.
doi:10.1371/journal.pone.0006115.g010
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59Fe from the duodenum of mice
expressing PrP. Wt and PrP
+ samples show similar levels of iron,
confirming the above results (Figure 10A, lanes 1 and 3).
Quantification of
59Fe in the first 10 cm of duodenum samples
shows an increase in PrP
KO samples by 132% relative to Wt controls,
and an increase in littermate PrP
KO by 238% relative to littermate
PrP
+ controls (Figure 10C). As expected, Wt and PrP
+ samples show
minimal difference in their
59Fe content (Figure 10C, lanes 1 and 3).
Quantification of
59Fe in the blood, liver, spleen and femur shows
similar incorporation in Wt and PrP
+ controls, and higher levels in
PrP
KO mice as observed in Figure 7 above (Figure 11). These
observations demonstrate that the deficiency of iron uptake in PrP
KO
mice is reversed by the expression of PrP in the PrP
+ mice.
Discussion
In this report, we demonstrate that the absence of PrP induces
systemic iron deficiency in PrP
KO mice, a phenotype that is
rescued by re-introducing PrP on the PrP
KO background. Relative
to normal Wt mice of the same genetic background, PrP
KO mice
exhibit lower levels of iron in the plasma, brain, liver, and spleen,
and the major iron metabolism proteins show a compensatory
response by increasing the levels of iron uptake proteins Tf and
TfR, and decreasing the levels of iron storage protein ferritin. The
underlying cause of iron deficiency in PrP
KO mice is likely to be
two-fold; 1) inefficient transport from duodenal enterocytes to the
blood stream, and 2) impaired uptake by target cells of various
organs, including the hematopoietic precursor cells. We previously
reported that PrP functions as an iron uptake and transport
protein in human neuroblastoma cells in vitro [13]. This report
supports and extends those findings by demonstrating a similar
function of PrP in mouse models, a novel function for a protein
known mostly for its role in the pathogenesis of prion disorders.
It is surprising that the mere absence of PrP alters iron
metabolism in both enterocytes and hematopoietic cells since
distinct processes regulate iron uptake and transport at these sites.
Figure 11. Distribution of
59Fe in PrP
(+) and PrP
KO litter-mates. Distribution of
59Fe in the blood, liver, spleen, and femur after 4 hours of
chase shows similar incorporation in Wt and PrP
(+) mice in the organs tested, and significantly more
59Fe in the spleen and femur of PrP
KO mice as
noted above. One way ANOVA shows a significant difference among Wt, PrP
KO, and PrP
(+) samples (p,0.0001). Post hoc Bonferroni tests show
significant difference in
59Fe in littermates PrP
(+) and PrP
KO organs relative to Wt controls (*p,0.01; **p,0.05). Littermate PrP
(+) shows a significant
difference compared to PrP
KO counterpart (#p,0.01). Values are mean6SEM of three independent experiments.
doi:10.1371/journal.pone.0006115.g011
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study, is mediated by the divalent metal transporter 1 (DMT1) at
the apical (AP) plasma membrane of duodenal epithelial cells.
Here, duodenal cytochrome b (DcytB) functions as a ferric
reductase and reduces Fe(III) iron to the Fe(II) form for transport
to the cytosol by DMT1. Absorbed iron is transported through the
cytosol by poorly characterized mechanisms and is exported from
the basolateral (BL) membrane by the concerted effort of
ferroportin (FPT) and hephaestin, a multicopper oxidase that
oxidizes Fe(II) iron to the Fe(III) form for uptake by Tf in the
systemic circulation [19].
Based on our observations, it appears that PrP mediates iron
export from the BL membrane of enterocytes to the blood stream
rather than uptake from the intestinal lumen. This conclusion is
supported by our observations demonstrating accumulation of
orally administered radioactive iron (
59FeCl3) in the duodenal
enterocytes of PrP
KO mice that persists until eleven days of chase
when almost all
59Fe from Wt controls has been transported out.
Most of the
59Fe accumulates in ferritin within these cells, a
surprising observation given the state of iron deficiency in these
mice. Ferritin protein expression is also up-regulated in PrP
KO
enterocytes, probably reflecting a response to increased iron influx
from the AP plasma membrane, decreased transport from the BL
membrane, or a combination of the two processes. Although
limited amounts of
59Fe are released into the blood stream of
PrP
KO mice during the first hour of chase, the amount is
significantly lower compared to Wt controls. Furthermore, PrP is
expressed on the BL surface of MDCK cells, a polarized epithelial
cell line, and inter-cellular junctions of mouse enterocytes [20,21],
suggesting a functional role at the BL domain rather than the AP
plasma membrane. It is surprising that PrP
KO mice excrete
relatively less
59Fe in their feces despite the iron loaded state of
their enterocytes (unpublished observations). It is likely that this
response reflects an attempt to conserve and utilize the absorbed
iron by PrP
KO mice due to their chronic state of iron deficiency.
A similar phenotype of systemic iron deficiency resulting from
accumulation of absorbed iron in the duodenal epithelium has
been reported in sex-linked anemia (Sla) mice due to a mutation in
the intestinal ferroxidase Hephaestin [22]. Based on our data, it is
likely that PrP functions upstream from hephaestin, perhaps as a
ferric-reductase, to reduce Fe(III) iron stored in ferritin to the
Fe(II) form for transport across the BL membrane and subsequent
oxidation by hephaestin for delivery to circulating Tf. It is
interesting to note that PrP has been reported to perform a similar
function in copper transport where it reduces copper (II) prior to
its delivery to cytosolic copper (I) carrying proteins [23]. It seems
unlikely that PrP is an active ferroxidase based on a previous
report [13] and our current observations on the rate of iron efflux
from peritoneal macrophages of PrP
KO mice. However, differen-
tial activity of PrP in different cell lines cannot be ruled out,
leaving it unclear whether PrP indeed functions as a ferroxidase
like hephaestin. Since the iron deficiency in PrP
KO mice is largely
compensated and the animals live normally except for delayed
erythropoiesis after induced hemolysis and specific deficiencies
restricted mainly to the central nervous system [5,12], it is likely
that PrP modulates the function of other iron uptake proteins or is
involved in a parallel pathway that compensates for its absence.
Identification of such proteins and pathways would be a significant
step forward in understanding the role of PrP in iron export from
the duodenum.
Absence of PrP also compromises the ability of hematopoietic
precursor cells to take up iron from plasma Tf, an interesting
observation since these cells acquire most of their iron by the Tf/
TfR pathway. A similar phenotype of iron deficiency has been
reported in neuroblastoma cells expressing lower levels or mutant
forms of PrP, another cell line that utilizes the Tf/TfR pathway for
acquiring iron [13]. It is therefore likely that PrP functions at a
point where the enterocyte and the Tf/TfR pathway of iron
uptake and transport intersect. Normally, plasma Tf provides iron
to most cells of the body, and itself receives iron from three main
sources; 1) food via the duodenum and proximal jejunum, 2)
recycled senescent RBCs, and 3) iron stores within macrophages
and hepatocytes. Most of the iron taken up from food is utilized for
erythropoiesis, and RBCs contain 80% of the total body iron. Iron
rich Tf binds to the TfR on hematopoietic precursor cells, and the
Tf/TfR complex is endocytosed through clathrin mediated
endocytosis. Tf bound iron is released in the acidic environment
of the endosomes, reduced by the ferric reductase Steap3, and
transported across the membrane by DMT1 to cytosolic ferritin
for storage. Ferritin maintains the cellular labile iron pool to
provide for the metabolic needs of cells, and is itself regulated by
the iron content of cells through iron management proteins [22–
26]. It is surprising that the mere absence of PrP compromises the
ability of parenchymal cells of various organs and hematopoietic
precursor cells to take up iron.
PrP
KO mice show an earlier and a significantly higher spike in
59Fe uptake by the spleen and long bones relative to Wt controls.
Since RBCs consume the majority of plasma iron and the spleen
and long bones are the principal sites of erythropoiesis, these
findings reflect an abnormally high rate of erythropoiesis in PrP
KO
mice. The presence of
59Fe labeled cells in the peripheral blood of
PrP
KO mice after four hours of chase is surprising given the time it
takes for RBCs to mature, and may reflect the binding of
59Fe-Tf
to TfR positive immature erythrocytes. However, while Wt RBCs
continue to incorporate
59Fe, PrP
KO RBCs show only a modest
increase even after eleven days of chase. These results suggest that
the erythropoiesis in PrP
KO mice is ineffective despite adequate
supplies of iron in the spleen and long bones, probably due to
inefficient uptake by the hematopoietic precursor cells. The
alternate possibility, i.e., increased turnover of RBCs in the spleen
or intravascular hemolysis is unlikely based on the following
observations: 1)
59Fe counts did not increase in the spleen of
PrP
KO mice at any time point after four hours of chase, the main
organ where RBCs are turned over and the released iron recycled,
2) PrP
KO RBCs did not show a decline in
59Fe counts during
eleven days of chase given that the normal half-life of mouse RBCs
is ,15 days, 3)
59Fe from hemolyzed RBCs was not detected in the
urine, and 4) markers of hemolysis such as hemoglobinuria were
not detected in PrP
KO mice (unpublished observations). Further-
more, the kinetics of
59Fe uptake from the plasma of Wt and
PrP
KO mice suggests decreased uptake by target organs rather
than increased hemolysis in the latter. The precise biochemical
pathway by which PrP facilitates iron uptake by the parenchymal
and hematopoietic precursor cells is difficult to define from our
data. However, based on our observations from neuroblastoma
cells [13], it is likely that PrP facilitates transport across the
endosomal membrane to the cytosol by functioning as a ferric
reductase. Further studies are required to resolve this question.
The iron deficiency in PrP
KO mice is mild since overt signs of
anemia were not detected except for a mild reduction in
hemoglobin levels, a significant reduction in serum iron, serum
ferritin, and transferrin saturation, and an increase in the total iron
binding capacity and the number of circulating reticulocytes. This
observation is surprising given the obvious decrease in brain iron
content, a privileged organ that is affected last by iron deficiency
[27]. It is likely that the response of iron management proteins
compensates for the iron deficiency in PrP
KO mice in all major
organs, including the hematopoietic system. Introduction of PrP
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KO background reverses the iron deficient phenotype
completely, indicating that PrP is an integral component of the
iron homeostatic machinery that feeds into the major pathways of
iron uptake and transport.
In conclusion, this report demonstrates a significant role of PrP
in maintaining systemic iron homeostasis. Specifically, PrP
modulates iron transport from the duodenum to the blood stream
and uptake by cells of the hematopoietic system, brain, liver, and
spleen. Since major proteins and pathways of iron transport and
uptake utilized by enterocytes and hematopoietic cells differ
significantly [26], these observations suggest a functional role for
PrP at a point downstream from these pathways. Although our
data fall short of identifying the specific role of PrP in iron
modulation, this report establishes the functional role of PrP in
iron metabolism, and provides essential information on the
possible sites where PrP influences iron metabolism independently,
or by intersecting with known pathways of iron uptake and
transport. Since imbalance of iron homeostasis is a common
feature of prion disease affected human, hamster, and mouse
brains [14], these results suggest a significant contribution of loss of
PrP function to prion disease pathogenesis.
Materials and Methods
Materials and antibodies
PrP-specific monoclonal antibody 8H4 (against residues 145 to
180) was obtained from Abcam (Cambridge, MA, USA) and from
Drs. Man-Sun Sy and Pierluigi Gambetti (Case Western Reserve
University). Rabbit anti-human ferritin antibody that cross-reacts
with H and L-chains of mouse ferritin was obtained from Sigma
(catalog # F5012, lot number 117K4880), ferritin H-chain specific
antibody was from Santa Cruz (Catalog # sc-25617, lot # L0104),
ferritin L-chain specific antibody was also from Santa Cruz
(Catalog # sc-25616, lot # E0905), anti-Tf was from GeneTex
(San Antonio, TX), anti-TfR from Zymed Laboratories Inc
(Carlsbad, CA), and horseradish peroxidase (HRP)-conjugated
secondary antibodies were from GE Healthcare (Little Chalfont,
Buckinghamshire, United Kingdom). All other chemicals were
purchased from Sigma.
Transgenic mice
The PrP
KO mice in the FVB background (FVB/Prnp
0/0) were
originally obtained from George Carlson, (McLaughlin Research
Institute). The PrP
+ transgenic mice expressing wild type murine
PRNP were created by microinjection of the half-genomic PrP
clone [28] into fertilized FVB/Prnp
0/0 eggs. The transgenic mice
were screened by PCR and maintained via breeding with FVB/
Prnp
0/0 mice. The genotype of littermate PrP
KO and PrP
+ mice
were determined by PCR of DNA from ear punches.
Intestinal iron uptake and transport
All procedures with mice were performed according to the
guidelines established by the Animal Resource Center of Case
Western Reserve University, and were based on protocols
approved by the IACUC committee. Three to six month old
age- and sex-matched Wt and PrP
KO mice maintained under
similar conditions were fasted overnight with water ad libitum, and
20 mCi of
59FeCl3 diluted in 0.2 ml of PBS was administered orally
with an olive-tipped gavage needle. The mice were chased on
normal chow for 1 h, 4 h, 24 h, 48 h and 11 days. At each chase
time point, a set of Wt and PrP
KO mice were euthanized, and
blood was collected by cardiac puncture in heparinized vials.
Plasma and red cells were separated by centrifugation at
5,000 rpm for 5 min. Stomach and upper gastro-intestinal tract
was separated and rinsed with cold PBS until clean. The samples
were placed on a filter paper, vacuum dried, and subjected to
autoradiography. The brain, liver, spleen, and femur were
collected, washed with PBS, and snap frozen on dry ice. The
organs were weighed, and radioactivity was counted in a c-
counter. Selected samples of brain were fixed in 5% phosphate
buffered formalin for 24 h, and 700 mM thick sections were cut
using a Leica vibrotome. Cut sections were briefly air-dried and
exposed to X-ray film.
Native gradient gel electrophoresis, autoradiography and
immunoblotting
Native gradient gel electrophoresis, autoradiography, and
immunoblotting were performed essentially as described by Vyoral
et al. [29] and in a previous report [13].
SDS-PAGE and Western blotting
Brain, liver, and spleen homogenates (10%) prepared in lysis
buffer were resolved by SDS-PGE and subjected to western
blotting using specific antibodies as described in previous reports
[30]. Immunoreactive bands were visualized by ECL detection
system (Amersham Biosciences Inc.).
Prussian blue staining
Snap frozen liver and spleen sections (7 mm) were immersed in
acidified potassium ferrocyanide solution (4%) for 20 min followed
by washing with distilled water. Sections were then counterstained
with 1% Neutral Red for 2 min and mounted.
Determination of plasma and tissue iron
In-gel iron estimation of protein bands and the iron content of
liver and spleen homogenates were performed by Ferene-S
staining essentially as described [14]. Serum iron, total iron
binding capacity and transferrin saturation were determined by
using an automated Ferene based detection method on a
Dimension RXL chemistry analyzer (Dade Behring, Deerfield,
Ill). The CBC and reticulocyte data was determined on a Sysmex
XE-2100 hematology analyzer (Kobe, Japan). To detect hemoly-
sis, urine dip-stick was performed on an Urisys 2400 urine
analyzer (Roche Diagnostics, Indianapolis IN).
Transferrin binding assay
Tf binding sites in the brains of Wt and PrP
KO mice were
assessed by incubating 10 mM thick brain sections prepared from
frozen samples essentially as described by Moos et al. [17]. In
short, brain sections were pre-incubated with 0.2% bovine serum
albumin in PBS for 30 min at 37uC in a humid atmosphere to
wash off endogenous Tf, and incubated with FITC-Tf (5 mg/ml)
for 30 min at 37uC in a humid chamber. Another set of samples
was pre-incubated with apo-transferrin (75 ng) for 10 min at room
temperature followed by incubation with FITC-Tf as above. The
sections were rinsed with PBS, mounted, and observed using a
laser scanning confocal microscope (Bio-Rad MRC 600).
Estimation of iron export from peritoneal macrophages
Peritoneal macrophages were isolated from Wt and PrP
KO mice
as described by Hanazawa et al. [18]. Following an overnight
culture, adhered macrophages were stimulated with LPS (100 ng/
ml) for 24 h, serum starved for 1 h, and labeled with
59FeCl3-
citrate complex (1 mM sodium citrate and 2 mCi of
59FeCl3 in
serum free DMEM for 4 h at 37uC. The molar ratio of citrate to
iron was maintained at 100:1. Cell surface bound iron was washed
and the cells were chased in complete medium for different time
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point and counted in a c-counter. After 18 h the cells were lysed
and cell associated
59Fe was measured in a c-counter.
Statistical analysis
A minimum of 3 mice in each group were analyzed for all
experiments, and the experiments were repeated at least 3 times.
The results are expressed as mean6standard error of mean (SEM).
Statistical analysis was done by unpaired Student’s t test when
comparing Wt with PrP
KO group. For comparing Wt, PrP
KO and
littermates groups, one way ANOVA followed by Bonferroni
multiple comparison post hoc test was done using GraphPad Prism
software (Version 5.02, GraphPad Inc., San Diego, CA, USA).
Differences were considered significant at p,0.05.
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